Biobusiness Development Grants Awarded

Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions. 

 

View bio business grants awarded by year.
James Thompson, PhD
Molecular farming to reduce cost of recombinant proteins important to regenerative medicine
After completing "proof of concept" experiments that produced human proteins in tobacco plants and acquiring a new lab facility, we seek to upscale…
2017-2018
John Schorgl, BA
AmnioStent - Combining nitinol scaffold with amnion tissue to create a novel airway stent technology for tracheobronchial applications
Peytant Solutions is developing a human amnion tissue cover scaffold, called the AmnioStent™, for the treatment of malignant airway strictures.…
2017-2018
Walter C. Low, PhD
Production of dopamine neurons - a cellular product for treating Parkinson’s
The goal of this project is to produce authentic human dopamine neurons that can be used for cell transplantation therapy for patients with…
2017-2018
Saad Kenderian, MD
Development of a chimeric antigen receptor T cell therapy platform at the Mayo Clinic
The goal of this project is to establish the infrastructure for the development of chimeric antigen receptor T (CART) cell therapy at the Mayo…
2017-2018
Yasuhiro Ikeda, DVM, PhD
Mayo CRM-original iPSC-derived islet product in a retrievable, encapsulation device
Our product is MC-iLETS01, Mayo Center for Regenerative Medicine-original iPSC-derived islet cell product in a retrievable encapsulation device,…
2017-2018
Leah Hogdal, PhD
Mitochondrial base editing for nerve regeneration
We intend to use a new form of genetic correction we’ve developed to correct mitochondrial gene mutations that cause a progressive form of…
2017-2018
James Dutton, PhD
Critical infrastructure to support new stem cell-derived treatments for patients with age-related macular degeneration in Minnesota
  Age-related macular degeneration (AMD) is a devastating disease of aging and the leading cause of blindness in people aged 50 and older in…
2017-2018
Dan Dragomir-Daescu, PhD
Controllable and automated system for synthesizing GMP magnetic nanoparticles for regenerative medicine applications
The goal of this project is to implement non-expendable research laboratory equipment in the Mayo Clinic Center for Regenerative Medicine, which…
2017-2018
Daniel Carlson, PhD
Development of inducible immunodeficient swine
Immunodeficient swine have tremendous potential in basic and pre-clinical research; however, difficulties in propagation have impeded commercial…
2017-2018
Dennis Wigle, MD, PhD
Development of A Novel Adult Stem Cell-based Drug Discovery Platform at Mayo Clinic
Using the extensive biobank of human induced pluripotent stem cells (n > 250) housed within the Mayo Clinic Center for Regenerative Medicine…
2016-2017
Henry Walker, MA
Lyophilization Device
Lyophilization is a frequently employed technique that is highly aligned with the goals of the Advanced Product Incubator (API), a non-cell based,…
2016-2017
Kent Vilendrer, MS, MBA
Regenerative Medicine Bioreactor Drive System Development
This grant will fund the development of a fully-automated, computer-controlled drive system that will provide pulsatile flow to a large number of…
2016-2017